Csir

Korea Institute of Science and Technology

Phytopharm Plc

Conopco, Inc.

Csir of Scientia

Vinesh Jaichand Maharaj

Roelof Marthinus Horak

Gerda Fouche

Eric Khorombi

John Hakkinen

Young-Joo Kim

Jungyeob Ham

Hak Cheol Kwon

Hyun Ok Yang

Joon Ki Kim

Sung-Kwon Chung

Jin Wook Cha

Fanie Retief Van Heerden

Robin Alec Learmonth

Rudzani Nthambeleni

Rory Desmond Whittal

Robert Vleggaar

Dashnie Naidoo

Marina Van Der Merwe

Jeremiah Senabe

Ebrahim Wadiwala

Louis Gabriel Jozua Ackerman

Xolani Mthembu

Louis Ackerman

Marina Mikhailovna Van Der Merwe

A pharmaceutical composition and a food composition including extracts ofsp. for treating dementia, which compositions inhibit the formation of &#x3b2;-amyloid, and a method of preparing the extracts.

Composition for preventing or treating dementia comprising extracts of monsonia species

Composition and method for preventing and/or treating dementia and ameliorating memory impairment and/or improving memory, comprising one or more arylnaphthalene lignan derivatives, namely Justicidin A, 5-methoxyjusticidin A, Chinensinaphthol, and a pharmaceutically-acceptable salt thereof, as active ingredient.

Composition containing arylnaphthalene lignan derivative for preventing and/or treating dementia

The invention provides the use of an extract of a plant of the genusand at least one compound selected from quercitin-3'-O-glucoside, trans-3-O-galloyl-3,3&#x2032;,5,5&#x2032;,7-pentahydroxyflavan, taxifolin-3&#x2032;-O-glucoside, catechin and epicatechin in the preparation of a medicament for the treatment of benign prostatic hyperplasia (BPH). The mode of action is by a route selected from blocking the conversion of testosterone to dihydrotestosterone by inhibiting the 5&#x3b1;-reductase enzyme or by reducing oxidative stress or both.

Management and treatment of benign prostatic hyperplasia

A process for the production of a substance or composition for the therapeutic or prophylactic treatment of erectile dysfunction or the enhancement of libido in a male human or animal subject comprises the step of formulating the substance or composition from at least one of plant material and an extract of plant material of at least one plant species of the family Geraniaceae.

Treatment of erectile dysfunction and libido enhancement

The invention provides the use of at least one plant selected from plants of the family Zingiberaceae in the preparation of a medicament for use in the treatment or prophylaxis of allergic diseases. The plant is optionally selected from the generaandand the species is optionally selected fromand. The allergic disease is selected from asthma and atopy.

Preventative treatment and remission of allergic diseases

A method of reducing gastric acid secretion in animals including humans comprising administering an extract of a plant of the genusorto animals, generally mammals.

Gastric acid secretion

A pharmaceutical composition contains an extract obtainable from a plant of the genusorcontaining an appetite suppressant agent having the formula (1). A process for obtaining the extract and a process for synthesizing compound (1) and its analogues and derivatives is also provided. The invention also extends to the use of such extracts and compound (1) and its analogues for the manufacture of medicaments having appetite suppressant activity. The invention further provides novel intermediates for the synthesis of compound (1) 

Pharmaceutical compositions having appetite suppressant activity

The present application relates to the reduction of gastric acid secretion in animals including humans; to methods of treating conditions or disorders associated with or exacerbated by gastric acid secretion; to pharmaceutical compositions useful in carrying out such methods; and to the use of certain extracts and compounds in the treatment of human and non-human animals, generally mammals.

Growing community of inventors

Pretoria, South Africa

Vinesh Jaichand Maharaj